54
Participants
Start Date
July 17, 2017
Primary Completion Date
April 25, 2023
Study Completion Date
April 25, 2023
Ifetroban Oral Capsule
Subjects will be treated with oral ifetroban daily for 8 weeks
Placebo Oral Capsule
Subjects will be treated with oral placebo daily for 8 weeks
Montefiore Medical Center, The Bronx
Rochester Regional Health, Rochester
University of Pennsylvania, Philadelphia
University of Virginia Medical Center, Charlottesville
Wake Forest Baptist Health, Winston-Salem
Emory University School of Medicine, Sinus, Nasal, and Allergy Center, Atlanta
The Research Center, Hialeah
Vanderbilt University Medical Center, Nashville
Advanced ENT & Allergy, Louisville
Deaconess Clinic, Evansville
Kansas City Allergy and Asthma Associates, PA, Overland Park
Banner University of Arizona Medical Center, Asthma & Airway Disease Research Center, Tucson
Scripps Clinic - Carmel Valley, San Diego
Antelope Valley Clinical Trials, Lancaster
Stanford University Medical Center, Stanford
UT Southwestern Medical Center, Dallas
Lead Sponsor
Cumberland Pharmaceuticals
INDUSTRY